Answer:
C. The second statement is correct
Distributive strategies focus on dividing the pie and integrative strategies on expanding the pie.
Explanation:
Distributive negotiation is a type of negotiation that both parties agrees to sharing existing resources within themselves so that they can part ways and it's mostly a win-lose situation while the integrative negotiation is a type where both parties seek to further expand the existing resources be looking forward to a collaborative process, it's always a win-win situation for both parties.
The variance analysis cycle<u> C. begins with the preparation of </u><u>performance reports</u><u>.</u>
<h3>What is a performance report?</h3>
A performance report is at the heart of the variance analysis cycle.
The performance report details the following:
- Calculates the difference between actual and budgeted expenditure and revenue.
- Analyzes the differences into various variances, determining if they are favorable or unfavorable or have no effects.
- Investigates the reasons for the differences.
- Puts the information together and reports to management.
Thus, the variance analysis cycle<u> C. begins with the preparation of </u><u>performance reports</u><u>.</u>
Learn more about performance reports and variances at brainly.com/question/13287252
You want us to write it for you lol?
Answer:
- I think Ben should encourage the Senior Management to call a multidisciplynary meeting and do some research.
Explanation:
<em>I think Ben is right</em>. Even though the statement is technically correct, it may mislead customers.
Customers may interpret the phrase "<em>no sugar added</em>" as if the product did not contain any sugar.
Thus, customers interested in drinking beverages without sugar at all might think they are "safe" consuming the smoothie beverage, when in reallity each <em>smoothie's bottle contains sugar 35 g of naturally occurring sugars from the fruit.</em>
Customers deserve to be certain on what they are buying, thus the labels must be a sincere help for them, and not ambiguos at all.
This is a "gray zone" and an example of what in ethics is called a dilema.
I think the decision should be shared by a wider team and based on some research.
I think Ben should encourage the Senior Management to call a multidisciplynary meeting, where the subject is widely discussed. Also, I would suggest Ben to do some research, look for precedents about labeling in the industry, and try to learn the opinion of the FDA about this sensitive matter.
